Kriya Taps New CMO for Rare Disease Therapeutics Division
Kriya Therapeutics tapped longtime pharma veteran Pedro Huertas as chief medical officer of its rare disease division.
Source: biospace.com
Stay updated with breaking news from Warden Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kriya Therapeutics tapped longtime pharma veteran Pedro Huertas as chief medical officer of its rare disease division.
Durham gene therapy company Kriya Therapeutics has purchased neighboring startup Warden Bio, for an undisclosed sum, to expand its rare diseases capabilities.